Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3263461000168113 | Bydureon BCise (exenatide 2 mg / 0.85 mL) modified release injection, 4 x 2 mL pen devices (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3263471000168119 | Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices | Is a | Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices | true | Inferred relationship | Some | ||
| Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices | has TPUU | Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device | true | Inferred relationship | Some | 1 | |
| Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices | has container type | pen device | true | Inferred relationship | Some | ||
| Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices | has TP | Bydureon BCise | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR